HIT Consultant

AUGUST 26, 2024

OTCQB: HRGN) , a clinical-stage biotechnology company focused on developing organ regeneration technology for severe diseases, has secured approximately $5 million from a new investor through a private placement of shares. What You Should Know: – Harvard Apparatus Regenerative Technology, Inc.

Biotechnology 96

Biotechnology Life Sciences 96

HIT Consultant

OCTOBER 18, 2024

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.

Integration 88

Integration Life Sciences Biotechnology Healthcare 88

The Rand Blog

DECEMBER 29, 2023

The Saudis have set their sights on becoming leaders at the cutting edge of technology development in everything from biotechnology to semiconductors and artificial intelligence. And they appear to be prepared to pay top dollar to do it. This complicates U.S. critical technology strategy.

Biotechnology 102

Biotechnology 102

HIT Consultant

OCTOBER 10, 2024

Glook Appoints Mike Alvarez as Chief Executive Officer Mike Alvarez, CEO at Glooko Mike Alvarez brings over 20 years of leadership experience in the medical device and biotechnology industries to his role as CEO of Glooko.

Biotechnology 98

Biotechnology Integration Healthcare 98

HIT Consultant

AUGUST 27, 2024

By leveraging advanced biotechnology, ZBiotics enables consumers to actively engage in healthier living through probiotics engineered for specific use cases that solve real-world problems. ZBiotics is fundamentally driven by the mission to improve health through modern biotechnology. Led by a team of dedicated Ph.D.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

OCTOBER 13, 2022

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Biotechnology 98

Biotechnology Regulations Prevention Integration 98

HIT Consultant

AUGUST 13, 2024

This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development. What You Should Know: – Quantiphi , an AI-first digital engineering company, announced a strategic minority investment in Transcell , a pioneering stem cell-based biotech innovator.

Life Sciences 52

Life Sciences Biotechnology Integration Healthcare 52

Bill Of Health

OCTOBER 6, 2024

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (PFC) seeks an experienced, dynamic, passionate, and flexible Communications Manager to support, promote, and creatively amplify the work of PFC with the overall goal of raising its profile and advancing its mission. Come work with us!

Biotechnology 40

Biotechnology Accountability Integration 40

Bill Of Health

AUGUST 28, 2024

Interviewed by William Leonard Pickard Alex Zhavoronkov, PhD , is Founder and CEO of Insilico Medicine, a leading clinical stage biotechnology company developing next-generation artificial intelligence and robotics platforms for drug discovery, with headquarters in Cambridge, MA and facilities around the world.

Biotechnology 87

Biotechnology Pharmaceuticals 87

HIT Consultant

AUGUST 19, 2024

a biotechnology company pioneering a novel approach to early cancer detection. What You Should Know: – Accenture today announced a strategic investment in Earli Inc. , – Earli’s groundbreaking technology aims to transform cancer diagnosis and treatment by enabling the rapid and accurate identification of cancerous cells.

Biotechnology 52

Biotechnology Pharmaceuticals Life Sciences 52

HIT Consultant

SEPTEMBER 11, 2024

What You Should Know: – Gilead Sciences , a global biopharmaceutical company, and Genesis Therapeutics , an AI-focused biotechnology firm, have announced a strategic collaboration to discover and develop innovative small molecule therapies.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

JANUARY 8, 2024

What You Should Know: – Amgen , a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja. “Freyja embodies our commitment to leveraging the convergence of technology and biotechnology. Reese, Amgen’s Chief Technology Officer.

Biotechnology 52

Biotechnology Life Sciences 52

Bill Of Health

OCTOBER 17, 2023

It seems, in the near term, that the “who” would probably be a venture-backed biotechnology company — a corporate actor. Open questions abound for cell-based testing services, but perhaps the first among them would be: who would offer them?

Biotechnology 113

Biotechnology Regulations Medical Technology 113

HIT Consultant

APRIL 6, 2023

a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock. What You Should Know: Biostage, Inc.,

Biotechnology 98

Biotechnology Life Sciences 98

HIT Consultant

MAY 17, 2024

– Under this collaboration, Trinity Biotech will provide a pool of unique multi-parameter CGM datasets from Trinity Biotech’s existing biosensor database to PulseAI.

Biotechnology 52

Biotechnology Health Analytics Life Sciences 52

HIT Consultant

AUGUST 6, 2024

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care. – The survey of 475 patients explored attitudes toward weight management, treatment preferences, and information sources.

Biotechnology 74

Biotechnology Healthcare Providers Healthcare 74

HIT Consultant

MARCH 30, 2023

What You Should Know: – Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungry Gut test.

Biotechnology 95

Biotechnology 95

HIT Consultant

SEPTEMBER 29, 2023

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology. – The patent (No.

Biotechnology 105

Biotechnology Life Sciences 105

HIT Consultant

NOVEMBER 2, 2022

Dr. Squinto joins from OrbiMed Advisors and brings more than 30 years of experience in the biotechnology company building and investing space, having co-founded and built numerous biotechnology companies including Alexion Pharmaceuticals and acting as a key scientific founder of Regeneron Pharmaceuticals. Joining Dr.

Life Sciences 98

Life Sciences Biotechnology Pharmaceuticals Healthcare 98

Bill Of Health

AUGUST 26, 2022

Myriad Genetics could boost investment in biotechnology R&D. Although genetic and other biotechnological research often begins in universities under federal funding, patents were clearly the focus of the university scientists racing to identify BRCA1 and BRCA2, as well as a gene relevant to Alzheimer’s.

Biotechnology 52

Biotechnology Pharmaceuticals 52

Bill Of Health

JUNE 16, 2023

Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. By Minsoo Kwon The legalization of cannabis has raised ethical, regulatory, and scientific questions. This article highlights key points made during the conversation.

Biotechnology 105

Biotechnology Regulations Hospitals 105

Bill Of Health

SEPTEMBER 13, 2023

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from Harvard Law School. At the law school, Adithi is interested in examining how emerging biotechnologies in regenerative medicine intersect with patient privacy and other ownership rights.

Biotechnology 59

Biotechnology Medical Technology Prevention Healthcare 59

HIT Consultant

OCTOBER 14, 2022

Obatala Sciences, a New Orleans biotechnology company, was founded in 2017 to enable diversity in clinical research and speed up the development of better therapies for diseases like obesity, diabetes, and cancer, and advance research in tissue engineering and regenerative medicine. Trivia Frazier, Ph.D.,

Biotechnology 97

Biotechnology Pharmaceuticals Healthcare Innovation Prevention 97

Bill Of Health

APRIL 28, 2023

The Petrie-Flom Center Student Fellowship is a competitive one-year program designed to support Harvard graduate students interested in pursuing independent scholarly projects related to health law policy, biotechnology, and bioethics.

Biotechnology 53

Biotechnology Law Firms 53

HIT Consultant

DECEMBER 7, 2023

What You Should Know: Insilico Medicine (“Insilico”) , a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, today announced that the company has initiated the first-in-human study for ISM5411, a potentially first-in-class PHD inhibitor for the treatment of inflammatory bowel disease (IBD).

Biotechnology 98

Biotechnology Regulations 98

HIT Consultant

NOVEMBER 18, 2021

Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. As biotechnology companies come under increased pressure to deliver breakthroughs, they are turning to modern software to digitize all their scientific processes and centralize their data. Recent Traction/Milestones.

Biotechnology 96

Biotechnology Life Sciences Pharmaceuticals Accountability 96

Bill Of Health

OCTOBER 2, 2024

The  Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics  is pleased to announce our 2025 annual conference: “Law, Healthcare, and the Aging Brain and Body.” This year’s conference is organized in collaboration with Nina A. Kohn , the David M.

Biotechnology 40

Biotechnology Healthcare 40

HIStalk

NOVEMBER 6, 2022

Top News Roche, the world’s largest biotechnology company, unifies its.

Biotechnology 64

Biotechnology 64

HIT Consultant

JUNE 6, 2024

The Res_Q platform offers pharmaceutical, medical device, and biotechnology companies a cloud-based solution with an open API architecture. Automating these processes is the only way to eliminate this validation debt,” said Ellen Reilly, CEO of Sware.

Life Sciences 59

Life Sciences Biotechnology Pharmaceuticals Integration 59

HIT Consultant

OCTOBER 30, 2023

United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and a pipeline that includes four ongoing registration-phase studies. Miromatrix Background Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells.

Life Sciences 52

Life Sciences Biotechnology Healthcare 52

Healthcare It News

SEPTEMBER 9, 2022

It is funded through the state's Australian Medtech Manufacturing Centre and Biotechnology Fund and is being delivered by digital health accelerator ANDHealth. Programme to support clinical entrepreneurs launched in WA. A new programme to support clinical entrepreneurs has been launched in Western Australia.

Biotechnology 175

Biotechnology Doctors Hospitals Healthcare 175

HIT Consultant

SEPTEMBER 21, 2022

Founded in 2017, Naveris is a privately held biotechnology company with facilities in Massachusetts and North Carolina. The company has also partnered with biotechnology companies developing immunotherapies for HPV-related cancers. Using DNA Fragmentomics Technology to Detect Cancer Earlier.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

JANUARY 3, 2022

HCS), a company focused on helping patients adhere to and benefit from pharmaceutical and biotechnology products. CareMetx, LLC, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today the acquisition of Human Care Systems, Inc.

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare 98

Healthcare ECONOMIST

APRIL 8, 2024

If the EMA evaluates a pharmaceutical and grants it marketing authorization, this determination is binding all all European Union member states. cell and gene-therapy) also in 2008.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Regulations 98

HIT Consultant

MAY 16, 2024

What You Should Know: – Phenomix Sciences (Phenomix) , a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and Labcorp , and existing investors, including Health2047.

Biotechnology 52

Biotechnology Pharmaceuticals Healthcare Providers Healthcare 52

Bill Of Health

DECEMBER 8, 2023

It did not introduce unprecedented enablement principles, and, in practice, biotechnology genus claims, including antibody claims, were already limited. The other possibility is that Amgen will only affect the patentability of antibodies, which long received more lenient treatment than other biotechnologies.

Biotechnology 52

Biotechnology Life Sciences Pharmaceuticals Regulations 52

HIT Consultant

OCTOBER 7, 2021

The firm is continuing to add new pharmaceutical and biotechnology companies to its client base, in new therapeutic areas, and has continued to expand with the addition of over 100 new employees so far in 2021.

Biotechnology 96

Biotechnology Pharmaceuticals Life Sciences 96